Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04386577Phase 3Unknown
Phase 3, randomised, double-blind trial in aging, sponsored by Augusta University. Primary endpoint: Changes in telomere length at 4 years. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04386577.